Embed Size (px)
Citation preview
conferenceseries.com
8th World Congress on
July 16-17, 2018 Melbourne, AustraliaBreast Cancer & Therapies
Delving into the Advances in Breast Cancer Research
Tentative Program
150+Participation Interactive
Sessions
15+KeynoteLectures
10+PlenaryLectures
50+Workshops5+
MeetingsB2B
https://breastcancer.cancersummit.org/
Tentative Program
July 16-17, 2018 Melbourne, Australia
8th World Congress on
Breast Cancer & TherapiesProgram at a Glance
Time Session08:30-09:30 Registrations09:30-11:30 Keynote Forum
Group Photo11:30-11:45 Network & Refreshments Break*
11:45-13:00 Breast Cancer- Present Perspective | Screening, Detecting and Diagnosing Breast Cancer | Breast Cancer-Clinical Trials
13:00-13:45 Lunch Break**
13:45-16:00 Breast Cancer Therpy , Prevention and Medicine | Surgery Choices for Breast Cancer | Breast Cancer Stages
16:00-16:15 Network & Refreshments Break*16:15-18:00 Personilized Medicine- A Redefined Treatment | Lifestyle and Breast Cancer | Case Studies
Day Concludes
July 16, 2018 Monday
Time Session09:30-11:30 Immunology and Breast Cancer | Rehabiliation/Survivorship after Treatment | Breast Cancer11:30-11:45 Network & Refreshments Break*
11:45-13:00 Breast Cancer Nursing | Breast Cancer and Pregnancy | Breast Reconstruction | Prevention of Breast cancer
13:00-13:45 Lunch Break**13:45-16:00 Controversies Related to Breast Cancer | Current and Future State16:00-17:00 Poster Presentations
Award CeremonyConference Concludes
July 17, 2018 Tuesday
• Breast Cancer- Present Perspective• Screening, Detecting and Diagnosing
Breast Cancer• Breast Cancer Therpy , Prevention
and Medicine• Surgery Choices for Breast Cancer• Personilized Medicine- A Redefined
Treatment• Breast Cancer-Clinical Trials• Breast Cancer Stages• Lifestyle and Breast Cancer• Alternative and Complementary
Medicine
• Immunology and Breast Cancer• Rehabiliation/Survivorship after
Treatment• Breast Cancer• Case Studies• Breast Cancer Nursing• Breast Reconstruction• Prevention of Breast cancer• Breast Cancer and Pregnancy• Controversies Related to Breast
Cancer• Current and Future State
Major Scientific Sessions
• You will be given about 5-7 minutes to present your poster including questions and answers. Judges may pose questions during the evaluation of the poster• Judges will even evaluate the student’s
enthusiasm towards their study, interest and knowledge in the area of their research
• The winners will be announced at the closing ceremony of the conference. The decision of the winner will be withdrawn if the winner/winners is/are not present at the time of announcement
• Apart from the judging time you may also be present at the poster to share your research with interested delegates
• Present your research through oral presentations • Learn about career development and the latest research
tools and technologies in your field • This forum will give pertinent and timely information
to those who conduct research and those who use and benefit from research
• Develop a foundation for collaboration among young researchers
• The forum will provide an opportunity for collegial interaction with other young investigators and established senior investigators across the globe
• Interact and share ideas with both peers and mentors
General [email protected]
Best Poster Award Young Researchers Forum
Conference VenueMelbourne, Australia
Contact usAmerica: Conference Series llc LTD
Breast Cancer 201847 Churchfield Road, London, W3 6AY
Tel: +44-800-098-8455Phone: 1-650-889-4686, Fax: +1-650-618-1417,
Toll free: +1-800-216-6499Email: [email protected]
Contact usUK: Conference Series llc LTD
Breast Cancer 201847 Churchfield Road, London, W3 6AY
Tel: +44-800-098-8455 Email: [email protected]
Contact us Asia-Pacific: Conference Series llc LTD
Breast Cancer 2018Divyasree Building, Raidurg
6th Floor, North Block Hyderabad 500032, INDIA
Tel: 040-33432295Email: [email protected]
Glimpses of Breast Cancer Conferences
Glimpses of Breast Cancer Conferences
TOURIST DESTINATIONS IN MELBOURNE, AUSTRALIA
Royal Botanic Gardens Victoria
Melbourne Luna Park
Royal Exhibition Building
Federation Square
Melbourne Cricket Ground
Breast Cancer 2018conferenceseries.com
Conference VenueMelbourne, Australia
Venue & AccommodationMercure Albert Park65 Queens RoadMelbourne 3004 – Australia
Contact usHarikanth PProgram DirectorBreast Cancer Summit 2018Conference Series llc LTD47 Churchfield Road, London, W3 6AYT: 1-650-889-4686 | F: +1-650-618-1414Email: [email protected]: +1-800-216-6499
https://breastcancer.cancersummit.org/
Contact usBreast Cancer 2018
47 Churchfield Road, London, W3 6AYTel: +44-800-098-8455
Phone: 1-650-889-4686, Fax: +1-650-618-1417, Toll free: +1-800-216-6499
Email: [email protected]@cancersummit.org
Contact usUK: Conference Series llc LTD
Breast Cancer 201847 Churchfield Road, London, W3 6AY
Tel: +44-800-098-8455 Email: [email protected]
Contact us Asia-Pacific: Conference Series llc LTD
Breast Cancer 2018Divyasree Building, Raidurg
6th Floor, North Block Hyderabad 500032, INDIA
Tel: 040-33432334Email: [email protected]
conferenceseries.com
Tentative Program
http://breastcancer.conferenceseries.com/
Pioneering Spirit of Enriching the Lives and Wellness of Women
June 15-17, 2017 London, UK
5th World Congress on
Breast Cancer
***For available speaker slots***[email protected]@nursingmeetings.com
08:30-09:00 RegistrationsDay 1 June 15, 2017
Keynote ForumIntroduction
Title: Role of sphingosine-1-phosphate in estrogen receptor signaling in breast cancerSarah Spiegel, Virginia Commonwealth University School of Medicine, USATitle: Biomarkers that have prognostic and therapeutic importance for inflammatory breast cancer Yun Gong, University of Texas-M D Anderson Cancer Center, USA
Group Photo & Networking & Refreshments Break 10:20-10:40 @ Foyer Sessions: Breast Cancer Therapy, Prevention and Management | Breast Cancer-Present Perspective | Breast Cancer NursingSession Chair: Steven M Hill, Tulane University School of Medicine, USASession Co-chair: Manjeet Rao, University of Texas Health Science Center, USA
Session IntroductionTitle: FOXK2 aberration in breast cancersAmy Hong Zhang, University of Texas-M D Anderson Cancer Center, USATitle: Circadian/melatonin disruption by dim light at night drives human epithelial breast cancer to a metastatic phenotypeSteven M Hill, Tulane University School of Medicine, USATitle: The impact of Nolvadex to generic tamoxifen switch on side effects and patient compliance in hormone receptor positive breast cancer patientsBashar Zeidan, Royal Hampshire County Hospital, UKTitle: Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysisJill Brook Hervik, Vestfold Hospital Trust, NorwayTitle: Volkmann’s breast operation (modified radical mastectomy) and its value in modern treatment of breast cancer Valerijus Ostapenko, National Cancer Institute, Lithuania
Lunch Break 12:45-13:30 @ RestaurantTitle: Exhibitor presentation By Sophiagenetics SAGerald Martin, Sophiagenetics SA, SwitzerlandTitle: The use of high dose estrogens for the treatment of breast cancerCarole Verhoeven, Pantarhei Oncology BV, The NetherlandsTitle: Exclusive self-destruction of triple negative breast cancer cellsCohen-Armon, Tel-Aviv University, IsraelTitle: A functional cross-talk between GPER and IGF1/IGF1R signaling drives breast tumor angiogenesis via activation of the HIF-1α/VEGF transduction pathway Ernestina Marianna De Francesco, University of Manchester, UK
Networking & Refreshments Break 15:15-15:35 @ FoyerTitle: FoxM1 inhibition: A novel therapeutic avenue to treat breast cancers Manjeet Rao, University of Texas Health Science Center, USATitle: The effect of Internet-based breast cancer patient’s pathway on breast cancer patients’ empowering processAnne Ryhanen, The University of Turku, FinlandTitle: Relationships among body mass index, systemic immune-inflammation index and luminal subtype in the resistance to endocrine therapy of breast cancerQingxia Li, Hebei General Hospital, China
Panel Discussions
Opening Ceremony09:00-09:20conferenceseries.com
Conference Hall- Waterfront 1
Day 2 June 16, 2017Conference Hall- Waterfront 1
Keynote ForumTitle: Endocrine treatment of breast cancer: Current concepts to predict and prevent relapseHiltrud Brauch, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, GermanyTitle: Naturopathic doctor in complementary natural treatment and prevention of cancerLloyd Jenkins, Budwig Center, SpainSessions: Screening, Detecting, and Diagnosing Breast Cancer | Surgery Choices for Breast Cancer | Personalized Medicine for Breast Cancer TreatmentSession Chair: Uhi Toh, Kurume University School of Medicine, JapanSession Co-chair: Anne Ryhanen, The University of Turku, Finland
Session IntroductionTitle: Comparison of bilateral whole-breast ultrasonography versus magnetic resonance imaging in the setting of breast cancer stagingHongying He, University of Texas Health Science Center at Houston, USA
Networking & Refreshments Break 10:55-11:15 @ FoyerTitle: Oncoplastic and reconstructive surgery single institution experienceZhygulin Andrii, LISOD Israeli Cancer Care Hospital, UkrainTitle: Real-time indocyanine green (ICG) fluorescence imaging technique for the detection of SLNs in early-stage breast cancerUhi Toh, Kurume University School of Medicine, JapanTitle: Proteomic profiling of plasma and tissue proteins associated to mammographic breast density using the KARMA cohortMarike Gabrielson, Karolinska Institutet, SwedenTitle: Breast cancer in young women-Retrospective studyJana Slobodnikova, Alexander Dubcek University of Trencin, SlovakiaTitle: E-MPBC-imaging findings of a rare aggressive breast cancer subtype: Metaplastic carcinoma of the breastHale Aydin, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Turkey
Lunch Break 13:20-14:00 @ RestaurantYoung Researchers Forum
Title: Enhancement of radiosensitivity of human endothelial and breast cancer cells with melatonin by regulating angiogenesis and genes involved in estrogen biosynthesisAlicia González González, University of Cantabria, SpainTitle: Breast density in Chinese women: Using percentage and area measures from a quantitative techniqueTong Li, The University of Sydney, AustraliaTitle: Oncogenic protein kinase D regulating networks in invasive breast cancerYan Liu, Southeast University, ChinaTitle: Evaluation of diffusion weighted MR Imaging and 18F-FDG PET for monitoring triple negative breast cancer response to Cisplatin treatmentNguyen Thu Huong, Gunma University Graduate School of Medicine, Japan
Networking & Refreshments Break 15:20-15:40 @ FoyerPoster Presentation 15:40-16:00 @ Foyer
Title: Assessment of Breast Cancer occurrence among females at King Abdul Aziz Hospital, Al-Ahsa: A retrospective study from 2007-2014Eman M.G. Hassan, Cairo University, EgyptTitle: Radial scare- The Compar of Ultrasound Breast Imaging with Histopathology Slobodníková Jana, Alexander Dubček University in Trenčín, SlovakiaTitle: Inhibition of the orphan nuclear receptor estrogen related receptor alpha sensitizes breast cancer cells to DNMT inhibitorsMathieu Vernier, McGill University, CanadaTitle: Exploring the effects of an exercise programme on women with breast cancerRuth McCrea, St Margaret’s Hospital, United KingdomTitle: Problems of mammary prosthesis inserted for a long period Shintaro Asai, Nagoya Kyoritsu Hospital, Japan
Panel Discussion and Award Ceremony Day 3 June 17, 2017
Extended Networking & Lunch 12.30-13-30 @ Restaurant
Hosting Organizations: Conference Series LLC2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA
Ph: +1-702-508-5200 Ext: 8042, Fax: +1-650-618-1417, Toll free: +1-800-216-6499Conference Series Ltd
Heathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, UK, Tel: +1-800-216-6499Email: [email protected]; [email protected]
conferenceseries.com721st Conference
Scientific Program
Women’s Health & Breast CancerOctober 03-05, 2016 London, UK
3rd World Congress on
Page 10
Keynote ForumIntroduction
Title: Why the term of “low grade ductal carcinoma in situ” should be changed to “Borderline Breast Disease": diagnostic and clinical implicationsShahla Masood, University of Florida College of Medicine - Jacksonville, Florida, USATitle: Breast reconstruction using scaffold synthetic or biological Pier Luigi Santi, Italy University of Genova, Italy Title: Targeting triple-negative breast cancer by inhibiting cancer stem-like cell (CSC) expansionGuan Chen, Medical College of Wisconsin, USA
Group Photo & Refreshment Break@ Foyer
Special Session
Title: Can Art play A Role in Medicine and Survivorship?Shirley Bianca, GermanyTitle: How can I start? How to go forward after the trauma of cancer diagnosis Judith Edwards, Cansurviving.com, UK
Sessions: Breast Cancer Therapy | Breast cancer Rehabilitation/Survivorship | Breast Cancer- Clinical Trails
Session Chair: Brian W Booth, Clemson University, USASession Co-chair: M P Van Den Tol, VU University Medical Center,The Netherlands
Title: Obesity and breast cancer: Can an Aspirin a day really improve survival?Linda deGraffenried, University of Texas at Austin, USATitle: Remodeling of tannic acid cross-linked collagen type I induces apoptosis in ER+ and HER2+ breast cancer cellsBrian W Booth, Clemson University, USA
Lunch Break
Title: Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction: A prospective randomized trial Daphne Gschwantler-Kaulich, Medical University of Vienna, AustriaTitle: Obesity in post-menopausal women starting adjuvant aromatase inhibitors for breast cancer: Is there an effect of body mass index on outcome?Jamal Zekri, AlFaisal University, Saudi ArabiaTitle: BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cellsBing Cui, Chinese Academy of Medical Sciences & Peking Union Medical College, ChinaTitle: A nationwide pathology study on surgical margins and excision volumes after breast-conserving surgery: There is still much to be gainedM P Van Den Tol, VU University Medical Center, The NetherlandsTitle: Mitochondrial estrogen receptors and endocrine therapy responseAsli Giray Kurt, Baskent University, Turkey
Networking & Refreshment Break @ Foyer
Title: The impact of coordinated multidisciplinary cancer serviceJamal Zekri, AlFaisal University, Saudi ArabiaTitle: Metaplastic breast carcinoma: A single center experience in PakistanZarka Samoon, Aga Khan University Hospital, PakistanTitle: The ginger product 6-Shogaol shows promise in breast cancer treatment by inhibiting Breast Cancer Cells and Stem Cell like SpheroidsSuparna Sengupta, Rajiv Gandhi Centre for Biotechnology, Trivandrum, India
08:30-09:00 Registrations
October 03, 2016 | Day 1
Hall B
Opening Ceremonyconferenceseries.com
Page 11
Panel Discussion
Day 2 : October 04, 2016Hall B
Session Introduction
Keynote Forum
Title: Towards early stage detection of ovarian cancer via lysophosphatidic acid as a biomarkerMichael Thompson, University of Toronto, CanadaTitle: Incidence of hyperlipidemias among premenopausal Chinese breast cancer patients after adjuvant cytotoxic chemotherapy Winnie Yeo, Prince of Wales Hospital- Chinese University of Hong Kong, Hong Kong
Session IntroductionSessions: Breast Cancer- Present Perspective | Breast Cancer Surgery ChoicesSession Chair: Jun Yang, St Jude Children’s Research Hospital, USASession Co-Chair: Pooja Saini, University of Liverpool, UK
Title: Update on triple negative breast cancer Saranya Chumsri, Mayo Clinic, Jacksonville, USATitle: Hypoxia, epigenetics and estrogen receptor in breast cancerJun Yang, St Jude Children’s Research Hospital, USATitle: Not feeling sick from breast cancer: A framework on health status perceptions transition processMaude Hébert, University of Quebec, Trois-Rivieres, Canada
Refreshment Break @ Foyer
Workshop
Title: The influence of nonstandard type operations during metastatic breast cancer Gia Nemsadze, The Institute of Clinical Oncology, GeorgiaTitle: The influence of nonstandard type operations during metastatic breast cancer Diana Nemsadze, The Institute of Clinical Oncology, Georgia
Session to be Continued
Title: A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neo-adjuvant chemotherapy in estrogen receptor positive breast cancerChang Gong, Sun Yat Sen University, Guangzhou, ChinaTitle: Integrated Molecular Profiling of Breast CancerVessela N. Kristensen, University of Oslo, Norway
Lunch Break
Title: Preservation of Fertility in Breast Cancer Patients in Five Hospitals in PortugalVasco Fonseca, Portuguese Institute of Oncology - Lisbon, PortugalTitle: A systematic review of barriers and enablers to South Asian women’s attendance for asymptomatic screening of breast and cervical cancersPooja Saini, University of Liverpool, UKTitle: Current surgical, oncological and reconstructive outcomes of nipple sparing mastectomy: Results from a national multicentric registry with 1006 cases over a six-year periodMarco Bernini, Careggi University Hospital, ItalyTitle: The impact of consanguinity on breast cancer among Palestinian womenNaheel Herbawi Abu-Khalaf, Karma Clinic, PalestineTitle: The effect of Fordyce cognitive-behavioral happiness training on general health of primiparous womenAmeneh safarzadeh, Zahedan University of Medical Sciences, Iran
Panel Discussion
Networking & Refreshment Break@ Foyer
Poster Presentations
BCS-01Title: Advances in breast radiotherapy planning- Treat the breast, spare the rest! go prone!
Javeria Iqbal, Royal Free London NHS foundation Trust, UK
BCS-02Title: The psychological network of breast cancer
Ivan Montes Nogueira, Universidad Veracruzana, México
Page 12
BCS-03Title: Knowledge about weight and its effects on reproductive health outcomes
Kathy Shadle James, University of San Diego, USA
BCS-04Title: Assessment of the level of knowledge about breast cancer and related symptoms, screening and treatment
Maram Mohammed Alqahtani, King Saud University school of Medicine, Saudi Arabia
BCS-05Title: Assessment of the level of knowledge about breast cancer and related symptoms, screening and treatment
Mona Mohammed Almofarej, King Saud University school of Medicine, Saudi Arabia
BCS-06Title: Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer
Sergio Aguggini, ASST of Cremona, Italy
BCS-07Title: Smoking and obesity combine to increase breast cancer risk in a Native American population
Will Imbrie Moore, Chickasaw Nation Medical Center, USA
BCS-08Title: The transtheoretical model and breast cancer screening: Its application among Iranian women with a family history of breast cancer
Ziba Farajzadegan, Isfahan Medical sciences University, Iran
BCS-09Title: Oral health knowledge, attitude and behavior of pregnant women and their correlation with clinical status. (Babol 1393)
Hamed Hosseinkazemi, Babol University of Medical Science, Iran
Day 3 October 05, 2016Extended Networking & Lunch
Conference Series LLC2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
Conference Series LtdHeathrow Stockley Park Lakeside
House, 1 Furzeground WayHeathrow, UB11 1BD
United [email protected]
OMICS International6th Floor, North Block
Divyasree Building, Raidurg Hyderabad Telangana, INDIA-500032
Tel: [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
Bookmark Your Dates
Website: www.breastcancer.omicsgroup.comE-mail: [email protected]; [email protected]
June 15-16, 2017 London, UK
5th World Congress on
Women’s Health & Breast Cancer
2nd World Congress on
September 19-21, 2016 Phoenix, USABreast Cancer
Scientific Program
conferenceseries.com
Page 14
RegistrationsHall-A
Day 1 September 19, 2016
Group PhotoNetworking and Refreshment Break @ Foyer
Workshop on Bio- Active Natural Substancesin Breast Cancer TherapySession Chair: Shahla Masood, University of Florida College of Medicine–Jacksonville, USASession Co-Chair: Colleen Huber, Naturopathic Oncology Research Institute, USA
Session IntroductionTitle: The role of hyperthermia as complementary treatment in metastatic breast cancerAlexander Herzog, University of Sevilla, SpainTitle: The natural product, PGP-x1, its role in inhibition of P-glycoprotein and MDR-1 overexpression and its role as an adjuvant treatment of late stage solid tumorsJohn Oertle, Envita Medical Center, USATitle: Biochemical effects of pomegranate on cancer Ellie Wright, Naturopathic Medical Doctors of Arizona, USATitle: Biochemical effects of pomegranate on cancer William Nelson, Naturopathic Medical Doctors of Arizona, USATitle: Pancreatic enzymes and cancerLinda Isaacs, Nutritional Research and Educational Foundation, USA
Lunch Break @ FoyerBreast Cancer Therapy| Biology of Breast CancerSession Chair: Colleen Huber, Naturopathic Oncology Research Institute, USASession Co-Chair: Alexander Herzog, University of Sevilla, Spain
Session IntroductionTitle: RTK signaling in therapeutic resistance of erbB2-targeted therapy Bolin Liu, University of Colorado Anschutz Medical Campus, USATitle: Role of DNA methyltransferases in regulation of breast cancer stem cellsMuthusamy Thangaraju, Georgia Regents University, USATitle: Autologous bone marrow therapy to operative site following modified radical mastectomy to prevent flap complicationsSribatsa Kumar Mahapatra, VSS Institute of Medical Sciences and Research, IndiaTitle: Hormone receptor–positive breast cancer has a worse prognosis in male than in female patientsXiaoxian Li, Emory University, USATitle: FOXK2: A novel oncogene that is amplified and over-expressed in breast cancerHong (Amy) Zhang, The University of Texas-M D Anderson Cancer Center, USA
Networking and Refreshment Break @ FoyerTitle: Lactoferricin B peptide kills breast cancer cells in vitro: Potential for therapyEbenezer Chitra, Institute of Medical Research, MalaysiaTitle: Effect of an individualized diet in body composition of breast cancer patients attending a navigator program in Sonora, MexicoAna T Limon-Miro, The University of Sonora, Mexico
Opening Ceremonyconferenceseries.com
Keynote Forum
Introduction
Title: Why the term of low-grade ductal carcinoma in situ should be abandoned: Minimizing over diagnosis and overtreatmentShahla Masood, University of Florida College of Medicine–Jacksonville, USATitle: Breast cancer survivors’ choices in treatment and diet Colleen Huber, Naturopathic Oncology Research Institute, USA
Page 15
Title: Muscarinic modulation of paclitaxel actions on human breast cancerMaria E Sales, University of Buenos Aires, ArgentinaTitle: 70-gene signature (MammaPrint): Assessment using samples fixed in formalin and embedded in paraffin, obtained via diagnostic core-needle biopsiesJuan A Mieza-Arana, Cruces Universitary Hospital, Spain
Panel Discussion
Day 2 September 20, 2016Hall-B
Keynote ForumTitle: MicroRNA expression profiling to identify potential biomarkers in inflammatory breast cancer Lei Huo, The University of Texas MD Anderson Cancer Center, USATitle: Quality assurance in breast surgery- have we finally arrivedChintamani, Vardhman Mahavir Medical College, India
SymposiumFrom Breast Cancer Diagnosis through Treatment and Beyond: Our Academic Medical Center’s Multidisciplinary
Approach to Patient Care, Discovery, and LearningSession Chair: Lei Huo, The University of Texas MD Anderson Cancer Center, USASession Co-Chair: Chintamani, Vardhman Mahavir Medical College, IndiaTitle: Predictive and prognostic multigene breast cancer assays used in the clinical practice in the United States: Analysis of the national cancer data baseAmila Orucevic, University of Tennessee Medical Center, USATitle: Outcomes disparities for invasive breast cancer in rural communities are not related to delays in treatmentJames M McLoughlin, University of Tennessee Medical Center, USA
Networking and Refreshment Break @ FoyerTitle: Influencing factors and evolving trends for contralateral prophylactic mastectomy in breast cancer patientsSneha Bhat, The University of Tennessee Medical Center, USATitle: Valid statistical approaches for data driven analysis in breast cancer: Research avenues under patient protection and affordable care act (PPACA)Robert Eric Heidel, The University of Tennessee Medical Center, USATitle: Factors influencing decisions of breast cancer patients to follow-up on recommendations for genetic counselling – The University of Tennessee Medical Center experienceMegan McNeil, North Carolina State University, USATitle: Is preoperative breast MR for staging breast cancer still helpful-Our experienceGarnetta Morin-Ducote, The University of Tennessee Medical Center, USATitle: Non-Wire localization techniques for non-Palpable lesions: Moving beyond the wireJillian Lloyd, The University of Tennessee Medical Center, USASessions:Screening & Diagnosis for Breast Cancer|Breast Cancer Immunotherapy & Radiation Therapy|Innovative Therapeutic Apporaches in Breast CancerSession Chair: Amila Orucevic, University of Tennessee Medical Center, USASession Co-Chair: Garnetta Morin-Ducote, The University of Tennessee Medical Center, USA
Session IntroductionTitle: Clinical opportunities of SNP microarray in breast cancerHui Chen, The University of Texas MD Anderson Cancer Center, USATitle: Measuring risk of disease recurrence in breast cancer with a DNA methylation liquid biopsyBodour Salhia, University of Southern California, USA
Lunch Break @ FoyerTitle: Understanding and eliminating the stigmatism and myths associated with male breast cancerHerbert P Wagner, A Man’s Pink – Male Breast Cancer Advocacy Organization, USATitle: Understanding the epigenetic role of phytochemicals in suppressing the PhIP induced cytotoxicity in breast epithelial cellsAshok Jain, Albany State University, USA
Page 16
Title: Barriers to Breast Cancer Care: Cultural and Socioeconomic Challenges in the 21st CenturyMelissa Joyner, UTMB Galveston, USATitle: Influence of lifestyle factors on mammographic density and prevention of breast cancer: An overviewMagda Johanna Vandeloo, Hasselt University, BelgiumTitle: Starting hormone therapy immediately after histological diagnosis of breast cancerVasco Carvalho Lourenço Fonseca, Central Lisbon Hospital, Portugal
Networking and Refreshment Break @ FoyerTitle: Title: Molecular inversion probe technology generates high-quality HER 2 copy number data in formalin - fixed paraffin-embedded breast cancer tissueAlexis Bousamra, Allegheny Health Network, USATitle: Breast cancer: Small tumours and large axillary lymph nodes. A report of two casesJuan A Mieza - Arana, Cruces Universitary Hospital, Spain
Poster Presentations
BCC-01Title: SRGN interact with TGFβ2 and endow triple-negative breast cancer with higher metastasis propertiesZhimin He, Cancer Center of Guangzhou Medical University, China
BCC-02Title: Role of educational intervention in improving the knowledge, attitude and practice of Iranian women about breast self examinationJafari Shobeiri M, Tabriz University of Medical Sciences, Iran
BCC-03Title: Effect of an individualized diet in body composition of breast cancer patients attending a navigator program in Sonora, MexicoAna T Limon-Miro, The University of Sonora, Mexico
BCC-04Title: Importance of a multidisciplinary approach to breast cancer treatment in pregnancy: Case report of new diagnosis of pregnancy-Associated breast cancerJeremy Grant, Western Pennsylvania Hospital, USA
BCC-05Title: Targeted four-node sampling of axilla: A simple, reliable and cost-effective approach in the management of breast cancerMandeep Kaur, Vardhman Mahavir Medical College & Safdarjang Hospital, India
BCC-06Title: Claudin-4 as predictor of response to neo-adjuvant chemotherapy in breast cancerMandeep Kaur, Vardhman Mahavir Medical College & Safdarjang Hospital, India
BCC-07Title: Importance of a multidisciplinary approach to breast cancer treatment in pregnancy: Case report of new diagnosis of pregnancy-Associated breast cancerJessica Hoyson, Western Pennsylvania Hospital, USA
BCC-08Title: Effect of vedic hymns on response to neoadjuvant chemotherapy in breast cancer: A Randomized clinical studyMandeep Kaur, Vardhman Mahavir Medical College & Safdarjang Hospital, India
Panel Discussion
Day 3 September 21, 2016Hall-C
Sessions:Innovative Therapeutic Apporaches in Breast Cancer|Chemotherapy for Breast Cancer|Optimal Breast Cancer Pathology – OrganisationSession Chair: Ashok Jain, Albany State University, USASession Co-Chair: Herbert P Wagner, A Man’s Pink – Male Breast Cancer Advocacy Organization, USA
Session IntroductionTitle: Importance of histopathological diagnosis of apocrine carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma, in order to avoid ineffective chemotherapy toward triple-negative breast cancerYutaka Tsutsumi, Fujita Health University School of Medicine, JapanTitle: Acidosis-Dependent anti-cancer chemotherapeuticsHiroshi Kobayashi, Chiba University, JapanTitle: ZNF217, A key regulator of tumorigenesiswith powerful biomarker value in ER+ breast cancers Pascale A Cohen, University of Lyon, FranceTitle: Novel approach to target aggressive breast cancer cells using a cannabis compoundPierre-Yves Desprez, California Pacific Medical Center, USA
Page 17
Bookmark your dates
e-mail: [email protected]; [email protected]: breastcancer.omicsgroup.com/america
Conference Series LLC2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
Conference Series Ltd.Traian Str., No.61, Constanta 900720,
Romania, Tel: 0805-080048Heathrow Stockley Park Lakeside
House, 1 Furzeground Way, Heathrow, UB11 1BD, United Kingdom
OMICS International6th Floor, North Block, Divyasree
Building, Raidurg Hyderabad, Telangana, INDIA-500032
Tel: [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
Breast CancerOctober 16-18, 2017 San Francisco, USA
5th World Congress on
Title: Molecular profiling reveals actionable targets in breast cancer patientsGargi Basu, Clinical Curation, USATitle: Opportunistic breast screening in women using a handheld spectrometer as a screening tool Mandeep Kaur, Vardhman Mahavir Medical College & Safdarjang Hospital, India
Networking and Refreshment Break @ FoyerTitle: Suppressing lung metastasis of breast cancer by inhibition of VCAM-1 expression with nanomedicineZhiwen Zhang, Shanghai Institute of Materia Medica, ChinaTitle: Molecular targeting of the aurora-A/SMAD5 oncogenic axis enhances chemo sensitivity in breast cancer cellsAntonino B D’Assoro, Mayo Clinic College of Medicine, USATitle: Glucocorticoid signaling is a molecular mechanism underlying the heterogeneity of different subtypes of breast cancerJun Ling, The Commonwealth Medical College, USATitle: Role of specimen imaging as a reliable tool to assess the margin status following surgery for breast cancerMandeep Kaur, Vardhman Mahavir Medical College & Safdarjang Hospital, IndiaTitle: Comparison of cardiac and lung doses between free breathing and deep inspiration breath hold technique for breast irradiation - A dosimetric studyMohammad Faruk Hossain, GONO University, Bangladesh
Video PresentationTitle: Cytology techniques in diagnosis of breast lesions in resource poor settingsNandini Manoli, JSS Medical College, India
Lunch Break @ FoyerPanel DiscussionAward ceremony
OMICS International Conferences2360 Corporate Circle., Suite 400 Henderson, NV 89074-7722, USA
Phone: +1-650-268-9744, Fax: +1-650-618-1414, Toll free: +1-800-216-6499Email: [email protected]; [email protected]
Scientific Program
308th OMICS International Conference
August 03-05, 2015 Birmingham, UK
World Congress on
Breast Cancer
Track 1: Biology of Breast Cancer
Session Introduction
Session Chair: Shahla Masood, University of Florida College of Medicine-Jacksonville, USASession Co-chair: Christopher Busby, Environmental Research SIA, Latvian Academy of Sciences, Latvia
Title: The Breast Cancer Epidemic: Evidence For a Radiogenic CauseChristopher Busby, Environmental Research SIA, Latvian Academy of Sciences, LatviaTitle: Changes in Breast Cancer Pathology Reports After Second OpinionVicente Marco Molina, Hospital Quirón Barcelona, SpainTitle: The Unknown Predisposition Can lie Deep in the Family TreeSan Ming Wang, University of Nebraska Medical Center, USATitle: Origin of breast cancer metastasisGaspar Banfalvi, University of Debrecen, Hungary
Coffee Break
Title: Multiparameter characterization of breast carcinoma: subgross, microscopy, proteins, and genesTibor Tot, European Society of Pathology, SwedenTitle: Differentiation and histogenesis of syringomatous tumour of the nipple and low-grade adenosquamous carcinoma: Evidence for a common originWerner Boecker, University of Muenster, & Institute for Hematopathology, GermanyTitle: Microcalcification as an active phenomenon mediated by epithelial cells with mesenchymal characteristicsElena Bonanno, University of Rome Tor Vergata, ItalyTitle: A role for lipids and statins in breast cancer risk and prevention?Mieke Van Hemelrijck, King’s College London, London UKTitle: DNA methylation profiles in advanced breast cancerIvana Fridrichova, Cancer Research Institute, Slovak Academy of Sciences, SlovakiaTitle: Passive smoking, household exposure to PAH, GST polymorphisms and risk of breast cancerNelly H Alieldin, Cairo University, Egypt
Group Photo
Lunch Break
Symposium on“Implementing recent advances in breast cancer diagnosis and treatment: The University of
Tennessee Medical Center at Knoxville experience"Title: Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCC’s TNM staging system on overall survival of Caucasian females with breast cancer – an institution’s 10 year experienceAmila Orucevic, The University of Tennessee Medical Center, USATitle: Breast cancer in young age (≤40 years): The University of Tennessee Medical Center at Knoxville 10 year experienceDaniel H. Snyder, The University of Tennessee Medical Center, USA
RegistrationsDay 1 August 03, 2015
Opening CeremonyKeynote Forum
IntroductionShahla MasoodUniversity of Florida College of Medicine-Jacksonville, USA
ChintamaniThe Association of Breast Surgeons of India, India
Raj KumarThe Commonwealth Medical College, USA
Scientific Program
Hall - 2
Title: Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experienceMatthew Curzon, The University of Tennessee Medical Center, USATitle: HER2+ breast cancer: Pre and post adjuvant anti-HER2 therapy era - The University of Tennessee Medical Center at Knoxville 11 year experienceHeather Gage, The University of Tennessee Medical Center, USATitle: The role of intraoperative fluoroscopy to improve negative margin resection of partial mastectomies: a single institution experienceJames M. McLoughlin, The University of Tennessee Medical Center, USATitle: Using USA guidelines and standards of breast cancer care in an academic medical center: screening to survivorshipJohn L. Bell, The University of Tennessee Medical Center, USATrack 2: Breast Cancer Tests: Screening, Diagnosis and MonitoringTrack 3: HER2 Positive and Other Types of Breast Cancers
Session Introduction
Session Chair: Tibor Tot, European Society of Pathology, SwedenSession Co-chair: Elena Bonanno, University of Rome Tor Vergata, ItalyTitle: What factors affect breast screening practices and early diagnosis of breast cancer?Zakia Hossain, The University of Sydney, AustraliaTitle: Role of NFKB as a prognostic marker in breast cancer: a new tool in the horizonDiptendra K Sarkar, Institute of Post Graduate Medical education and Research, IndiaTitle: Comparison of Microwave Mamma Tomography (MMT) with Magnetic Resonance Imaging; Preliminary report of a new technique, Cerrahpasa experienceAkif Enes Arikan, Istanbul University, Turkey
Coffee Break
Title: The use of indocyanine green to detect sentinel nodes in breast cancer: a prospective studyDomenico Samorani, Santarcangelo Hospital, ItalyTitle: Metaplastic Carcinoma of the Breast and p16 positivity: what does it mean? Lubna Mushtaque Vohra, Ziauddin University Hospital, PakisthanTitle: Patient advocacy program for breast cancer patients in the eastern province "we care" Medhat Faris, King Fahd Specialist Hospital -Dammam, KSATitle: FSIP1, a new potential early screening marker for breast cancerCaigang Liu, Dalian Medical University, ChinaTitle: Improved frozen section examination of the retroareolar margin for prediction of nipple involvement in breast cancerJose Roberto Piato, University of Sao Paulo, BrazilTitle: Breast cancer mammography screening in Jordan: Limitations and future recommendationsMunir Abu-Helalah, Mutah University, JordanTitle: Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan between 1998 and 2008: a population-based studyYi-Cheng Hu, National Yang-Ming University, Taiwan
Panel Discussion
Day 2 August 04, 2015Hall - 2
Keynote ForumYvonne Paterson University of Pennsylvania, USA
Symposium on“Immunotherapy of Breast Cancer”
Title: HER-2/neu as a target for Listeria-based cancer immunotherapy for breast cancerYvonne Paterson, University of Pennsylvania, USATitle: Pre-clinical studies evaluating the safety and efficacy of a recombinant Listeria expressing HER2/neu in dogs with spontaneous HER2+ bone cancerNicola Mason, University of Pennsylvania, USATitle: Developing a First in Man Carbohydrate Mimetic Peptide Vaccine for Cancer: A Translational StoryTom Kieber-Emmons, University of Arkansas for Medical Sciences, USATitle: Cancer immunotherapy utilizing gene-modified T cells: from the bench to the clinicPhil Darcy, Peter MacCallum Cancer Centre, AustraliaTitle: Adenosine receptor 2A blockade increases the efficacy of anti-PD-1 through enhanced anti-tumor T cell responsesPaul Beavis, Peter MacCallum Cancer Centre, AustraliaTitle: Identification of CD4+ T cell epitopes specific for the breast cancer associated antigen NY-BR-1Stefan B. Eichmüller, German Cancer Research Center (DKFZ), Germany
Coffee BreakTrack 4: Chemotherapy for Breast Cancer
Session IntroductionSession Chair: Aysegul A. Sahin, The University of Texas MD Anderson Cancer Center, USASession Co-chair: Robert-Alain Toillon, Universite Lille 1, FranceTitle: Histopathologic Evaluation of Breast Specimens after Neoadjuvant Chemotherapy Aysegul A. Sahin, The University of Texas MD Anderson Cancer Center, USATitle: Implication of Tyrosine Kinase Receptor networks in therapy resistanceRobert-Alain Toillon, Universite Lille 1, FranceTitle: A novel oral formulation for cancer therapy, loaded in a slow release matrix for targeted deliverySitanshu Sekhar Lahiri, Amity University, IndiaTitle: Neoadjuvant therapy for early stage breast cancer: a new pathway to registration?Graham Ross, Roche Products Limited, UKTitle: OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bonePenelope Ottewell, University of Sheffield, UKTitle: Factors perceived to influence exercise adherence in women with breast cancer participating in an exercise program during adjuvant chemotherapyAnne Marie Husebø, University of Stavanger, NorwayTitle: Does copper transporter 2 (CTR2) quaternary structure and subcellular localisation determine sensitivity of breast cancer cell lines to platinum-based chemotherapies?Stephen Assinder, University of Sydney, Australia
Lunch BreakTitle: Downregulation of Ca2+-activated Cl- channel TMEM16A by histone deacetylase inhibition in breast cancer cellsSusumu Ohya, Kyoto Pharmaceutical University, JapanTitle: Role of Dietary Additives in Suppressing the PhIP Induced Cytotoxicity Ashok Jain, Albany State University, USATitle: Cross-talk between ER stress and the MEK/ERK pathway potentiates apoptosis in human triple-negative breast carcinoma cells: Role of a dihydropyrimidone, Nifetepimine Parimal C. Sen, Bose Institute, India Title: Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 ExpressionMona Abd Elazeem, Tanta University, EgyptTrack 5: Breast Cancer SurgeryTrack 6: Radiotherapy for Breast Cancer
Session IntroductionSession Chair: Chintamani, The Association of Breast Surgeons of India, IndiaSession Co-chair: Vicente Marco Molina, Hospital Quirón Barcelona, SpainTitle: Is Sentinel Lymph Node Biopsy Enough for Axillary Macrometastasis?Merdan Fayda, Istanbul University, TurkeyThe benefits of surgery for breast cancer liver metastases – a single center experienceNicolae Bacalbasa, University of Medicine and Pharmacy, RomaniaTitle: The Clinical Outcome of Reconstruction with Tissue Expander for Breast Cancer Patients with MastectomyDaisuke Ota, Mitsui Memorial Hospital, JapanTitle: No pec touch: a pre-shaped ADM for subcutaneous one-step breast reconstructionGiorgio Berna, University of Padua, ItalyTitle: Triple ABC Technique in Clinical Assessment in Breast Cancer DiagnosisSribatsa Kumar Mahapatra, Veer Surendra Sai Institute Of Medical Science & Research, IndiaTitle: Use of 3D photography to measure breast volume prior to breast reconstructionFarid Meybodi, Westmead Breast Cancer Institute, Australia
Coffee BreakTitle: When to do, when not to do: challenges for radiation oncologist in breast/chest wall radiotherapy in developing countryQuratulain Badar, Ziauddin Medical University & Hospital, PakisthanTitle: The importance of intraoperative ultrasound guidance to achieve negative margins for palpable and nonpalpable breast cancerGuldeniz Karadeniz Cakmak, Bulent Ecevit University School of Medicine, TurkeyTitle: Melatonin sensitizes human breast cancer cells to ionizing radiationCarolina Alonso-González, University of Cantabria, SpainTitle: Radio-immunotherapy of cancer: Therapeutic efficacy, underlying mechanisms and potential applicationsInge Verbrugge, The Netherlands Cancer Institute, The NetherlandsTitle: Effect of e-feedback on knowledge about radiotherapy of breast cancer patientsMervi Siekkinen, University of Turku, FinlandTitle: Studies of the importance of Cytomegalovirus infection in breast cancerAfsar Rahbar, Karolinska University Hospital, SwedenTitle: Breast reconstruction with own tissue after mastectomy. A new microneurovascular technique with muscle sparing TRAM flapHelena K. Puonti, Savonlinna Central Hospital, Finland
Title: What do women want in breast reconstruction? Age-adhered surgery or rejuvenation?Helga Henseler, Hannover Medical School, Germany
Poster Presentations
PBC-01Title: Diagnostic utility of immunohistochemical staining for basal keratins, K5 and K14, and p63 in the differential diagnosis of malignant glandular lesionsIgor Buchwalow, Belgorod State University, Germany
PBC-02Title: Effect of butylphenylmethylpropional on DNA damage and repair in immortalised non-transformed human breast epithelial cellsAbdullah Farasani, University of Reading, UK
PBC-03Title: The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancerFadia JA. Gujam, University of Glasgow School of Medicine, UK
PBC-04Title: Care of Pregnant Women in GhanaAbugri Mavis, Ghana
PBC-05Title: Is Preoperative Axillary Ultrasound scan detection associated with clinicopathologic features at presentation in early-stage breast cancer?Lona Jalini, North Tees and Hartlepool University Hospital NHS Foundation Trust, UK
PBC-06Title: Analysis of ERBB2 rs2517956 in Breast Cancer Susceptibility-A study from IndiaVinish Ramachander, Osmania University, India
PBC-07Title: Breast cancer in male-to-female (MtF) transgender patients: is hormone receptor negativity a feature?David Archampong, Glan Clwyd Hospital, UK
Panel Discussion
Day 3 August 05, 2015Hall - 2
Track 7: Innovative Therapeutic Apporaches in Breast Cancer Diagnosis and Treatment Track 8: Breast Cancer Treatment Side EffectsTrack 9: Optimal Breast Cancer Pathology-Organisation
Session IntroductionSession Chair: Peter Weightman, University of Liverpool, UKSession Co-chair: Merdan Fayda, Istanbul University, TurkeyTitle: A new approach to the diagnosis of cervical, oesophageal and prostate cancer based on a combination of infrared and terahertz techniquesPeter Weightman, University of Liverpool, UKTitle: Diagnostic biomarkers in metastatic breast cancer Lei Huo, The University of Texas MD Anderson Cancer Center, USATitle: Management of skeletal health in patients with early breast cancer starting aromatase inhibitorsJamal Zekri, Al-Faisal University, Saudi ArabiaTitle: Inconsistent selection and definition of local and regional endpoints in breast cancer research Martine Moossdorff, Maastricht University Medical Center, The Netherlands
Coffee Break: Title: The breast cancer: a comparison among different diagnostic and therapeutic protocolsFederico Cattin, Udine University School of Medicine, ItalyTitle: PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34aArghya Adhikary, University of Calcutta, IndiaTitle: Knowledge of preventive measures towards breast cancer among nuns in Anambra State, NigeriaLaurette Philomena Nkem Madu, Immaculate Heart of Mary Mother of Christ Regional House, USA
Keynote ForumPhilippa D. DarbreUniversity of Reeding, UKS SahniIndraprastha Apollo Hospital, India
Title: Quercetin enhances sensitivity of MDA-MB231cells to doxorubicin by negative regulation of Nrf2 pathwayNasser Samadi, Tabriz University of Medical Sciences, IranTitle: Tumor microenvironment in breast cancer brain metastasesMihaela Lorger, University of Leeds, UKTitle: Circulating Tumour cells and Breast Cancer Heterogeneity Susan J. Done, University of Toronto, CanadaTitle: Breast Cancer: Presentation & limitation of treatment - Bangladesh perspectiveSaif Uddin Ahmed, BSM Medical University, Bangladesh Title: Mindfulness-based stress reduction for women diagnosed with breast cancerNicole Skoetz, University Hospital of Cologne, Germany
Lunch BreakWorkshop on Intraoperative Radiation Therapy
Title: Radical IORT: pros and cons; comparison of two trials ELIOT and TARGIT-A in breast cancer managementEsmaeil Akbari, Shahid Beheshti University of Medical Sciences, IranTitle: Radical IORT: pros and cons; comparison of two trials ELIOT and TARGIT-A in breast cancer managementNahid Nafissi, Cancer Research Center SBMU, IranTitle: Translation of Technical and Dosimetrical Verifications during Breast Cancer Intra-Operative Electron Beam Radiotherapy (IOERT)Seied Rabi Mehdi Mahdavi, Iran University of Medical Sciences, IranTitle: IORT indications and doses in Breast cancerHamid Reza Mirzaei, Shahid Beheshti University of Medical Sciences, IranTitle: Intra- Operative Radiotherapy for Breast Cancer treatment in Developing CountriesMaha Abdel Hadi, University of Dammam, Saudi ArabiaTrack 7: Innovative Therapeutic Apporaches in Breast Cancer Diagnosis and Treatment Track 8: Breast Cancer Treatment Side EffectsTrack 9: Optimal Breast Cancer Pathology – Organisation
Session IntroductionSession Chair: Raj Kumar, The Commonwealth Medical College, USASession Co-chair: Lei Huo, The University of Texas MD Anderson Cancer Center, USATitle: Impact of X-linked Tumour suppressor gene (FOXP3) variants on Indian Breast cancer patientsParveen Jahan, Maulana Azad National Urdu University, IndiaTitle: Investigating a new leptin-induced molecular mechanism that links obesity and oestrogen receptor-negative breast cancerHeba Alshaker, Petra University, JordanTitle: Mechanisms of Early Pregnancy-Mediated Breast Cancer ProtectionFabienne Meier-Abt, University Hospital of Basel, SwitzerlandTitle: Wide Local excision re-operation rates at Tameside General Hospital Katie Ludwig, Tameside General Hospital, UK
Coffee BreakTitle: Illitracy and Breast Cancer Screening Utilization: A Case Study of Saudi Women over 60 Years of Age Shareef Alqahtani, Johns Hopkins Bloomberg School of Public Health, USATitle: Heart rate variability and the use of complementary therapies in breast cancer survivorsDiaz-Rodriguez Lourdes, University of Granada, SpainTitle: Olive oil oleuropein has anti-breast cancer properties with higher efficiency on ER-negative cellsMaha H. Elamin, King Saud University, Saudi ArabiaTitle: The value of coping strategies in predicting posttraumatic growth in cancer patientsSara Mohammadizadeh, Islamic Azad University, IranTitle: Natural inhibitors and breast cancerSpeaker Slot availableYaghoub Safdari, Golestan University of Medical Sciences, Iran
Panel DiscussionAward Ceremony
OMICS Group Inc.2360 Corporate Circle, Suite 400Henderson, NV 89074-7722, USA
Ph: +1-888-843-8169Fax: +1-650-618-1417
OMICS International5716 Corsa Ave., Suite 110, Westlake
Los Angeles, CA 91362-7354, USAPh: +1-650-268-9744Fax: +1-650-618-1414
OMICS GroupSEZ Unit, Building No. 20, 9th Floor
APIIC Layout, HITEC CityHyderabad-500081, Telangana, INDIA
Ph: 040-40131823, [email protected]
Toll freeUSA & Canada: +1-800-216-6499
Australia: +1-800-651-097Europe: 0805-080048
2nd World Congress on
September 12-14, 2016 Phoenix, USABreast Cancer
Bookmark your dates
